Nuveen Asset Management, LLC Tg Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,688,651 shares of TGTX stock, worth $37.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,688,651

Previous 1,553,490 8.7%

Holding current value

$37.5 Million

Previous $23.6 Million 27.14%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$13.32 - $19.19 $1.8 Million - $2.59 Million	135,161 Added 8.7%	1,688,651 $30 Million
Q1 2024 May 13, 2024	BUY	$13.02 - $21.3 $2.64 Million - $4.32 Million	202,769 Added 15.01%	1,553,490 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $6.47 Million - $18.2 Million	968,611 Added 253.49%	1,350,721 $23.1 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $16,970 - $53,795	-2,030 Reduced 0.53%	382,110 $3.19 Million
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $2.15 Million - $4.87 Million	-139,197 Reduced 26.6%	384,140 $9.54 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $836,916 - $1.58 Million	-81,810 Reduced 13.52%	523,337 $7.87 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $416,421 - $983,285	83,118 Added 15.92%	605,147 $7.16 Million
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $658,180 - $1.21 Million	144,022 Added 38.1%	522,029 $3.09 Million
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $73,124 - $208,424	-19,552 Reduced 4.92%	378,007 $1.61 Million
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $503,737 - $1.32 Million	-64,499 Reduced 13.96%	397,559 $3.86 Million
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $3.6 Million - $8.42 Million	-237,061 Reduced 33.91%	462,058 $7.22 Million
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $883,984 - $1.64 Million	40,587 Added 6.16%	699,119 $21.9 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $587,502 - $885,049	-18,077 Reduced 2.67%	658,532 $25.5 Million
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $3 Million - $3.91 Million	-71,995 Reduced 9.62%	676,609 $32.6 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $144,544 - $314,028	5,720 Added 0.77%	748,604 $38.9 Million
Q3 2020 Nov 16, 2020	BUY	$18.49 - $27.24 $5.8 Million - $8.54 Million	313,670 Added 73.08%	742,884 $19.9 Million
Q2 2020 Aug 14, 2020	SELL	$8.9 - $21.84 $1.81 Million - $4.44 Million	-203,499 Reduced 32.16%	429,214 $8.36 Million
Q1 2020 May 14, 2020	BUY	$7.14 - $15.99 $2.28 Million - $5.1 Million	319,255 Added 101.85%	632,713 $6.23 Million
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $78,795 - $173,040	15,450 Added 5.18%	313,458 $3.48 Million
Q3 2019 Nov 14, 2019	BUY	$5.38 - $8.99 $9,802 - $16,379	1,822 Added 0.62%	298,008 $1.67 Million
Q2 2019 Aug 15, 2019	BUY	$6.27 - $8.65 $1.86 Million - $2.56 Million	296,186 New	296,186 $2.56 Million

Others Institutions Holding TGTX

# of Institutions

288

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.22B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Tg Therapeutics, Inc. Transaction History